In 1984 was created Natixis Private Equity, which is appeared as VC. The venture was found in Europe in France. The leading representative office of defined VC is situated in the Paris.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight LDK Solar, EyeGate Pharmaceuticals. Among the most successful fund investment fields, there are Biotechnology, Semiconductor. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The higher amount of exits for fund were in 2015. Opposing the other organizations, this Natixis Private Equity works on 31 percentage points more the average amount of lead investments. Considering the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2010.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Natixis Private Equity, startups are often financed by Societe Generale Asset Management, Motorola Solutions Venture Capital, Convergent Capital. The meaningful sponsors for the fund in investment in the same round are WI Harper Group, Ventech, UMC Capital.
The overall number of key employees were 1.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Arnerich Massena & Associates | Oregon, Portland, United States |
| Cedars Sinai Medical Center | California, Los Angeles, United States |
| Frescano Group | Stockholm County, Stockholms Lan, Sweden |
| Harlan Capital Partners LLC | New York, New York, United States |
| HealthInvest Equity Partners | Connecticut, Stamford, United States |
| Monarq Incubator | New York, New York, United States |
| NH Foods | Japan, Osaka, Osaka Prefecture |
| Omega Media | Norway, Oslo |
| Prasetia Dwidharma | Indonesia, Jakarta Pusat, Jakarta Raya |
| Qinglan Fund | China, Guangxi, Nanning |
| SDVentures | New York, New York, United States |
| SFJ Pharmaceuticals | California, Pleasanton, United States |
| Spansion | California, Sunnyvale, United States |
| SpringCapital Investment | Australia, New South Wales, Sydney |
| Step Venture Capital | China, Shanghai |
| Strathclyde University Incubator | Glasgow, Glasgow City, United Kingdom |
| Telemedia | Bellefonte, Pennsylvania, United States |
| Trinity Capital Investment | Arizona, Phoenix, United States |
| Velt Partners | Andalucia, Andalusia, Spain |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 